NDC 10019-646-64 - SUPRANE

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
10019-646
Requested NDC
10019-646-64
Package NDCs from labels
10019-646-60, 10019-646-24, 10019-646-64, 10019-646-34
Manufacturer
Baxter Healthcare Corporation
Effective date
2025-10-14
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
SUPRANE - Baxter Healthcare CorporationBaxter Healthcare Corporation2025-10-14HUMAN PRESCRIPTION DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
10019-646-24SUPRANE6 in 1 CARTONLIQUID617
10019-646-34SUPRANE6 in 1 CARTONLIQUID617
10019-646-60SUPRANE240 mL in 1 BOTTLE, GLASSLIQUID24017
10019-646-64SUPRANE240 mL in 1 BOTTLELIQUID24017

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
10019-646SUPRANE (DESFLURANE) LIQUID [BAXTER HEALTHCARE CORPORATION]14Current NDC, Legacy NDC, 4 package rows20240517_7f977eb6-c7c4-4dc5-ab3b-07414dbe5da5.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
10019-646-24ML - Milliliter10019-64692973b85-eb68-47e5-a4c3-85bf8e43a0f712012-07-24
10019-646-34ML - Milliliter10019-646c37b1b6a-9238-450f-b9a8-410467993ee012013-07-02
10019-646-64ML - Milliliter10019-6466db3ac42-afb0-4f73-a376-5c30601770d512016-02-04

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
DESFLURANEACTIVE INGREDIENTCRS35BZ94QSUPRANE (DESFLURANE) LIQUID [BAXTER HEALTHCARE CORPORATION]5
DESFLURANEACTIVE MOIETYCRS35BZ94QSUPRANE (DESFLURANE) LIQUID [BAXTER HEALTHCARE CORPORATION]5

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 ยท 7 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
SupraneDESFLURANEHenry Schein, Inc.a3e4c8e5-bff0-4a8f-8401-e9866c846ee22026-07-15Warnings, Adverse reactionsExact identifier
application number: NDA020118
rxcui: 562366
rxcui: 208919
unii: CRS35BZ94Q
DesfluraneDESFLURANEPiramal Critical Care Inc561c51aa-76fd-2eb8-e063-6394a90a70212026-07-08Warnings, Adverse reactionsExact identifier
rxcui: 562366
unii: CRS35BZ94Q
SUPRANEDESFLURANEBaxter Healthcare Corporation7f977eb6-c7c4-4dc5-ab3b-07414dbe5da52025-10-14Warnings, Adverse reactionsExact identifier
application number: NDA020118
ndc (package): 10019-646-24
ndc (package): 10019-646-64
ndc (package): 10019-646-60
ndc (package): 10019-646-34
ndc (product): 10019-646
ndc11 (package): 10019064664
rxcui: 562366
rxcui: 208919
spl id: afc83e0a-870e-4cae-a654-294efef7f6d9
spl set id: 7f977eb6-c7c4-4dc5-ab3b-07414dbe5da5
unii: CRS35BZ94Q
SUPRANEDESFLURANEBaxter Healthcare Corporation3fe3d468-d283-4dd0-a1a7-29291a9b2d0b2025-10-14Warnings, Adverse reactionsExact identifier
application number: NDA020118
rxcui: 562366
rxcui: 208919
unii: CRS35BZ94Q
SupraneDESFLURANEBaxter Healthcare Corporationefbb228b-7b38-4176-8bae-826103178c352025-10-14Warnings, Adverse reactionsExact identifier
application number: NDA020118
rxcui: 562366
rxcui: 208919
unii: CRS35BZ94Q
DesfluraneDESFLURANEPiramal Critical Care Inc80883017-6797-43b2-a500-36843e7e1aff2025-10-08Warnings, Adverse reactionsExact identifier
rxcui: 562366
unii: CRS35BZ94Q
DesfluraneDESFLURANESandoz Inc.21ba0e18-3dbc-4feb-a3a4-f6470c00910a2022-11-08Warnings, Adverse reactionsExact identifier
rxcui: 562366
unii: CRS35BZ94Q

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.